Biosimilars Research Reports
H4-13, Market Access, Pricing, and Reimbursement News in the Third Quarter of 2009
Topics: Biosimilars, Managed Care, General Pharmaceuticals, Regulation & Policy, Pricing
Regions: Japan, France, Germany
| Biosimilars: Beyond the First Product Wave
Topics: Biosimilars
| Biosimilars (2009 - 2014)
Topics: Biosimilars, Manufacturing, Packaging & Detailing
| The World Market for Biosimilars and the Potential for US Follow-on Biologics
Topics: Biosimilars, Genetic Engineering, Generics Drugs, Manufacturing, Packaging & Detailing
Regions: United States, Europe
| Biosimilars and Biobetters: Positioning for a New Market
Topics: Biosimilars, Generics Drugs
| Biosimilars Series: Forecast Analysis
Topics: Biosimilars, Manufacturing, Packaging & Detailing
| The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
Topics: Biosimilars, Pharmaceuticals Company Reports, General Pharmaceuticals, Manufacturing, Packaging & Detailing
| Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
Topics: Biosimilars
| Negotiating the Emerging Biosimilars Landscape: Key Developments in the Regulatory Environment
Topics: Biosimilars, Generics Drugs, Regulation & Policy
| Meeting the Challenges of Manufacturing Biosimilars
Topics: Biosimilars, Generics Drugs, Manufacturing, Packaging & Detailing
| European Biosimilars Market Outlook
Topics: Biosimilars, Manufacturing, Packaging & Detailing
Regions: Europe
| Biosimilars: A Viable Market - But When?
Topics: Biosimilars, Regulation & Policy, Research & Development, Drug Discovery
Regions: United States, Europe
| Biosimilars Series: Stakeholder Analysis
Topics: Biosimilars, Generics Drugs, Regulation & Policy
Regions: United States, Europe
| Biogenerics: The World Market for Biosimilars
Topics: Biosimilars, Generics Drugs
Regions: Global
| Biosimilars Series: Strategic Issues - Potential Remains Uncertain
Topics: Biosimilars, Pharmaceuticals, Generics Drugs, Regulation & Policy, Research & Development
| Biosimilars Series: Regulatory and Development Issues Hurdles Exist But Are Surmountable
Topics: Biosimilars, Pharmaceuticals, Generics Drugs, Regulation & Policy, Research & Development
| A Guide to Biosimilars, Biogenerics and Follow-On Biologics
Topics: Biosimilars, Generics Drugs, Regulation & Policy, Research & Development
Regions: United States, Europe
| The Future Of Biosimilars: Key Opportunities & Emerging Therapies
Topics: Biosimilars, Pharmaceuticals, Generics Drugs, Regulation & Policy
| Pricing and Reimbursement Issues for Generics and Biosimilars
Topics: Biosimilars, Biotechnology, Pharmaceuticals, Generics Drugs, Regulation & Policy
| Biosimilars: Benchmarking the key players - With increasing regulatory clarity and high revenue potential, interest in biosimilars increases
Topics: Biosimilars, General Biotechnology, Generics Drugs, Regulation & Policy, Drug Delivery, Drug Discovery
| Biosimilars: Regulatory Issues - Europe continues to make strides while the US lags behind
Topics: Biosimilars, Generics Drugs, Regulation & Policy
Regions: United States, Europe
| Biosimilars
Topics: Biosimilars, Generics Drugs, Regulation & Policy
|
<< Prev Next >>
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2009
|
